Swiss pharma companies likely to follow Pfizer-US price deal, business lobby says, ETPharma
Geneva: Swiss pharma companies are likely to follow Pfizer‘s price deal with the U.S. following President Donald Trump‘s…
Roche shares fall after breast cancer drug fails trial
Shares in Roche dropped more than 5% on March 9 after the Swiss pharmaceutical company announced that its…
Swiss pharma companies eye follow up to Pfizer-US pricing deal, business lobby says
By Olivia Le Poidevin and Cecile Mantovani GENEVA (Reuters) -Swiss drugmakers could strike their own deals with the…
What Does It Signal for 2026?
After a muted start to 2025, Big Pharma is back on the M&A trail. In just a month,…